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Abstract 
The pRB family, which includes p107 and p130 are known to control cell 
proliferation and differentiation (Mulligan and Jacks 1998). Their interactions with 
specific E2F transcription factors play a critical role in regulating the cell cycle 
progression. Wu et al, 2001 has shown that concomitant deletion of E2F1, E2F2, and 
E2F3 in Mouse Embryonic Fibroblasts (MEFs) renders them unable to proliferate. Since 
E2F1-3 have been implicated in driving expression of genes that promote the cell cycle, it 
was suggested that the inability of these cells to proliferate was due to a loss of gene 
expression. This in vitro analysis established that E2F3 must work alongside E2F1 and 
E2F2 to maintain normal proliferation. However, this conclusion had not been verified in 
differing cell types, and the in vivo importance of these conclusions was unknown. We 
show in this study that E2F1-3 are not required for cell proliferation or for differentiation 
of most cell types. Embryonic stem (ES) cells triply deficient for the E2F1-3 are able to 
proliferate, and teratomas formed from these cells are able to grow and differentiate. In 
vivo analysis using embryos triply deficient for E2F1-3 shows that they are able to 
survive until E9.5, suggesting that the activators are not essential during early 
embryogenesis. They are, however, critical for later stages of development. Similarly 
analysis of embryonic lenses deleted for E2F1-3 indicate their importance in particular 
tissues and highlights their potential role in cell cycle checkpoint regulation. The current 
study suggests a requirement for E2F1-3 in cell survival during development and begins 
to redefine the roles of E2Fs in vivo.  
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Introduction 
 Cellular proliferation, or cell division, is required for growth during development 
and tissue maintenance during adult life. Unchecked proliferation, however, can cause 
cancer which is characterized by populations of cells that proliferate outside normal 
constraints. Thus, tight regulation of the cell cycle is required for maintaining health. The 
Retinoblastoma (RB) gene was first identified as a tumor suppressor by its role in 
preventing the ocular pediatric cancer for which the gene is named. RB-heterozygous 
individuals are at high risk for developing retinoblastoma, and loss of RB has since been 
associated with many human cancers (Clarke et al. 1992; Lee et al. 1992; Maandag et al. 
1994). Extensive research in both humans and mice has been done to understand the 
mechanisms by which cell cycle progression is regulated by Rb. The pRb family, which 
includes p107 and p130 are known to control cell proliferation and differentiation 
through their interactions with specific E2F transcription factors (Mulligan and Jacks 
1998). The E2F family can be divided into four subclasses. The transcriptional activators, 
E2F1-3, are presumed to manage apoptosis and cell proliferation by both activation and 
repair of genes (Johnson et al. 1993). The second class, E2F4 and 5 are thought to 
maintain a repressive state. E2F1-5 share a pocket protein binding domain which allows 
them to interact with the pocket proteins (Müller et al. 1997). E2F6 through 8 are also 
considered transcriptional repressors. E2F6, the only known member of its group, forms 
complexes with polycomb-group proteins (PcG), while E2F7 and 8 are members of last 
classification and, unlike all other E2F family members, lack a dimerization partner (DP)-
binding domain and function independently of it (Atwooll et al. 2004). 
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 The classical mechanism by which the E2F family is presumed to function is 
characterized by presence of E2F4/p130 complexes on gene promoters in G0. As cells 
begin to enter the cell cycle at the G1/S transition, the E2F4/p130 complex leaves and is 
replaced by E2F/pRb. At this point, activated cyclin-dependent kinases (cdks) 
phosphorylate the Rb pocket proteins, which allow the E2F activators to dissociate, target 
genes are expressed and the cell cycle proceeds through S phase (Atwooll et al. 2004).  
Traditional knockout methods in mice have been used to identify the specific 
functions of E2F family members. In mammals and higher eukaryotes, functional 
redundancy may allow the loss of one E2F to be compensated by the role of another. This 
has made it difficult to analyze functional specificity among family members (DeGregori 
2002). In order to overcome these limitations, some investigators have knocked out 
combinations of genes to test for group functionality. Wu et al. (2001) tested for 
functional redundancy among the activator group and has shown that concurrent deletion 
of E2F1 and E2F3 or E2F2 and E2F3 results in embryonic lethality. This is in contrast to 
deletion of E2F1 and E2F2, which produces viable mice. This study pointed at a critical 
role for E2F3 in development. Furthermore, Wu et al., produced mouse embryonic 
fibroblasts (MEFs) from mice that carried a conditional allele for E2f3. This conditional 
allele allowed them to selectively eliminate E2f3 from the genome. With introduction of a 
retrovirus that expressed Cre recombinase, the LoxP-flanked (floxed) E2f3 alleles were 
excised from the genome. By combining the conditional allele of E2f3 with E2f1- and 
E2f2-null alleles, Wu et al., generated MEFs triply deficient for the E2F activators. While 
MEFs deficient for E2F1 and E2F2 proliferated rapidly, those deficient for E2F1 and 
E2F3 and those deficient for E2F2 and E2F3 proliferated at a reduced rate. Subsequent 
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analysis demonstrated that triply-deficient MEFs were unable to proliferate. Since 
activator E2Fs have been implicated in driving expression of genes that promote the cell 
cycle, it was suggested that the inability of the cells to progress through the cell cycle was 
due to a loss of gene expression. This in vitro analysis established that E2F3 must work 
alongside E2F1 and E2F2 to maintain normal proliferation (Wu et al. 2001).   
In stark contrast to the findings of Wu et al. and numerous other studies that 
highlight the central role that E2F plays in activation of G1/S phase-specific genes, we 
show in the current study that E2F activators are not required for cell proliferation or for 
differentiation of most cell types.  Embryonic stem (ES) cells triply deficient for the E2F 
activators are able to proliferate, and teratomas formed from these cells are able to grow 
and differentiate. In vivo analysis using embryos triply deficient for the activators shows 
that they are able to survive until E 9.5, suggesting that the activators are not essential 
during early embryogenesis. Furthermore, analysis of the embryonic lens facilitated a 
more careful investigation of cell cycle progression and differentiation in a highly 
organized organ in vivo. This study suggests that the current paradigm of how E2F 
regulates the cell cycle must be redefined and points to the critical role that E2F1-3 play 
in  the protection of cell survival in vivo.   
Materials and Methods 
Mouse Strains and Breeding 
 The E2f1, E2f2, E2f3, and Crystallin-cre (Cry-cre) transgenic mice used in this 
study were of mixed background C57B1/6-129/SV-FVB. Mice that were E2f1+/-; E2f2-/-
;E2f3+/-  as determined by PCR analysis were interbred for embryos triply deficient for 
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the E2F activators. Embryos were collected at E6.5, E8.5, E9.5, and E11.5 and either 
fixed in 10% buffered formalin or frozen in OCT.  
Derivation of Embryonic Stem Cells  
E2f1+/-; E2f2-/-;E2f3LoxP/LoxP mice and E2f1+/-; E2f2-/-;E2F3+/- mice were mated 
and blastocysts were collected prior to implantation at E3.5. The blastocysts were 
cultured with gamma-irradiated primary mouse embryonic fibroblasts in 24 well plates 
with REGRESO medium. Embryos were re-suspended with 0.25% trypsin-EDTA. Cell 
colonies displaying ES cell morphology were selected and subcultured between 7-14 
days post plating. E2f1-/-;E2f2-/-;E2f3LoxP/- colonies were determined by PCR and 
subsequently electroporated with Elongation Factor 1-cre plasmid. These ES cells were 
cultured in ES cell medium (15% FBS-DMEM, 6 mM glutamine, 0.1 mM MEM non-
essential amino acids, 0.1 mM 2-mercaptoethanol, and 1000-1500 units/ml LIF) for 4-6 
days and screened by PCR for recombination of the LoxP allele. The wild type control 
used in these experiments is the TC-1 stem cell line.  
Growth Curves 
For cell growth experiments ES cell lines were plated at equal density of 
approximately 895,400 cells suspended in 11ml of ES cell medium on successive plates. 
The medium was changed every other day. One plate was harvested each day for four 
days and cells were counted using Coulter Particle Counter Z1/D to measure growth rate. 
Teratoma Formation Assays 
TKO and DKO ES cell lines were derived as discussed above and cultured on 
feeder-free gelatin-coated tissue culture plates. Two million cells suspended in DMEM 
medium were subcutaneously injected into four sites on aythmic nude mice. These mice 
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were monitored for teratoma formation. Once the teratomas were detected, they were 
measured every three days. Mice were harvested between 25 and 55 days post injection 
for analysis. Teratomas were embedded in paraffin and sectioned.  
Lens Collection and Fixation 
Cry-Cre transgenic mice E2f1+/-;E2f2-/-; E2f3LoxP/LoxP were interbred for E2f1-/-
;E2f2-/-; E2f3LoxP/LoxP mice. Embryos were collected at E17.5 and fixed in a 10 percent 
buffered formalin solution. Genotypes were determined by PCR analysis. Heads were 
dissected and embedded in paraffin.  
Histology and Special Stains 
Pregnant mice were injected with bromodeoxyuridine, BrdU, 100 µg/g body 
weight, 2 hours before harvesting. Embryos and teratoma tissues were embedded in 
paraffin and sectioned or frozen in OCT and cryosectioned. Sections were stained by 
hematoxylin and eosin (H&E) staining for histological examination. Immunoflourescent 
staining for BrdU (1:50) incorporation was used to examine proliferation. 
Immunoflourescent staining with phopho-histone H2AX (Ser139) (1:100) antibody was 
used to quantify DNA double strand breaks. Subsequent slides were stained by Ki67 
antibody for proliferation. Apoptosis was examined by TUNEL with ApopTag 
peroxidase kit. Alcian Blue 2.5 was used to screen for acid mucopolysaccharides and 
cartilage. Masson trichrome stain was used to distinguish collagen and smooth muscle. 
Toluidine blue was used to detect the presence of mast cells. Alizarian Red S stains 
calcium deposits and other cations and was used to detect bone formation. Oil red was 
used to detect neutral fats. Proliferating cell nuclear antigen Pcna and mini-chromosome-
maintenance Mcm3 stains were used to characterize E2F expression in lenses. Antibodies 
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against alpha-, beta-, and gamma-crystallin (1:500) were used to detect protein 
expression in epithelial and fiber cells of the lenses. Antibodies against phosphorylated 
histone H3 (P-H3) (1:200) were used to monitor cell cycle entry.         
Results 
ES cells do not require E2F activators for proliferation 
E2F activators are believed to control cell cycle entry and target gene expression, 
and are directly implicated in cell proliferation. Wu et al. (2001) showed that MEFs 
deficient for E2F1-3 are unable to proliferate. This suggested that E2F1-3 have 
overlapping functions in the control of proliferation. This led us to examine more closely 
the growth of ES cells. Because ES cells are precursor cells that proliferate rapidly and 
differentiate in response to external signals, it seemed that if the E2F activators were 
indeed essential, they would be required for entry into the cell cycle and might even 
impact the differentiation process. 
In order to examine the role of the E2F activators in ES cells and their potential 
impact on proliferation, E2f1-/-;E2f2-/-;E2f3-/LoxP ES cell lines were derived. These were 
electroporated with a cre-expressing plasmid and resulted in recombination of the 
conditional E2f3 allele (E2f1-/-;E2f2-/-;E2f3-/Δ) in 58% of  the resulting clones. E2f1-/-
;E2f2-/-;E2f3-/LoxPand E2f1-/-;E2f2-/-;E2f3-/Δ, cell lines were plated at equal densities for 
comparison of growth rates. The wild type cell line (TC-1) which expressed normal levels 
of E2F1,2,3 protein was also plated for growth rate analysis (Figure A). Overall, the TC-1 
cell line grew more rapidly than the double knockout and triple knockout cell lines. There 
was no identifiable defect with loss of all three E2Fs, as results show that the triple-
knockout cells derived from one embryo grew faster than their double-knockout 
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counterpart.Conversely, triple-knockout cells from a second embryo grew at a slower rate 
than the double-knockout counterpart (Figure B). Importantly, we have found that, unlike 
MEFs, (Wu et al. 2001) ES cells are able to proliferate without E2F1-3.   
ES cells do not require E2F activators for differentiation  
 E2F1-3 appeared to be dispensable for proliferation, but we wondered whether 
E2F1-3 might impact differentiation of ES cells. Differentiation potential was assessed by 
two separate assays: growth of embryoid bodies and teratoma formation. Embryonic stem 
cells were grown on feeder-free bacteriological culture plates to prevent cells from 
adhering to the plate. LIF was removed from the medium to induce the cells to 
differentiate and the medium was changed every other day. Fifteen days post plating the 
cells were analyzed, and triple knockout, double knockout, and wild type cell lines were 
found to be equally capable of forming embryoid bodies. This suggested that there was 
no apparent defect in the ability of triple-knockout cells to differentiate nor were E2F1-3 
required for growth of these differentiated structures (Figure C).  
To confirm that E2F1-3 were not required for differentiation by a second, 
independent assay, ES cells were subcutaneously injected into athymic nude mice to 
qualitatively measure differences in differentiation potential. The rate at which double 
knockout and triple knockout teratomas formed was almost indistinguishable and relative 
size to harvest was consistent across genotypes (Figure D). The wild-type cell line 
produced teratomas that grew rapidly,consistent with what was found by the ES cell 
growth curve assays. Between 25 and 55 days, the mice were harvested and teratomas 
were collected. Histological analysis of the teratomas included both standard and special 
stains designed to detect differences in tissue types and components. The teratomas 
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analyzed by H&E staining showed that triple-knockout-derived teratomas were 
composed of most cell lineages and tissue types typical of teratomas (Kim et al. 2007) 
(Figures E & F). Cartilage and bone, however, were not found in any triple knockout 
samples analyzed. Teratomas were further analyzed by Alcian Blue 2.5, a copper 
phthalocyanin basic dye that detects acid mucopolysaccharides. Absence of alcian blue-
positive cells in the triple-knockout teratomas confirmed that cartilage had not formed 
(Figure G). Alizarian Red S, which detects calcium, was used to screen for bone 
formation (Figure H). Similarly, triple-knockout teratomas were the only samples lacking 
bone. Masson trichrome stain was used to distinguish between collagen and smooth 
muscle. This indicated that triple knockout teratomas contained more collagen than 
double-knockout and wild-type samples (Figure I). Toluidine Blue detected mast cells in 
all samples, and Oil Red O suggested that neutral fats were present in all samples. 
 It appeared that specific cell types might require E2F. To identify the nature of the 
requirement for E2F in different cell lineages, sections of teratomas were first stained by 
Ki67 antibody to detect cellular proliferation.  Quantitative analysis suggested that 
epithelial and neural cells were slightly less proliferative (Figure J & K).   Secondly, we 
sought to detect signs of programmed cell death with TUNEL staining, and found that 
specific cell types in triple-knockout teratomas appeared to have an apoptotic defect 
(Figure L). Neural and epithelial tissues had higher numbers of apoptotic cells than did 
other tissue types (Figure M). This suggests that there may be lineage-specific 
requirements for the E2F activators. Because apoptosis can be caused by accumulation of 
DNA damage or deregulation of the cell cycle, we checked for DNA damage by 
immunostaining with gamma-phosphorylated histone H2AX (γ-H2AX) antibodies. γ-
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H2AX immunofluorescent staining revealed that increased numbers of cells in epithelial 
tissue had double-strand breaks in DNA (Figure N & O), providing a possible 
explanation for the increase in apoptosis found with loss of E2F1-3 in the epithelium. 
Further, this suggests that E2F1-3 may help to stabilize the genome or signal to DNA 
repair mechanisms. Taken together, these findings point to a tissue-specific requirement 
for E2F1-3 in the control of proliferation, cell survival, and DNA damage prevention and 
repair.  
The E2F activators are not required in early embryonic development 
 To look at the in vivo relevance of the requirement for the E2F activators, we 
interbred E2f1+/-;E2f2-/-;E2F3+/- mice to obtain E2f1-/-;E2f2-/-;E2F3-/- embryos. Embryos 
were collected at E3.5, E6.5, E8.5, E9.5, and E11.5. One triply deficient live embryo was 
found at E3.5, five were found at E6.5, one at E8.5, three at E9.5, and one at E11.5. 
(Figure P). Embryos and associated placentas were examined histologically by H&E after 
sectioning. The triply-deficient embryos appeared to be of similar size and structure to 
littermates (Figure Q). BrdU incorporation at E6.5 indicated that embryos and extra-
embryonic components were similarly proliferative. Conversely, proliferation at E9.5, as 
measured by staining for Ki67, showed decreased numbers of proliferating cells in 
myocardium of the heart. TUNEL analysis at E6.5 suggested no difference in cell death 
among the embryos or extra-embryonic components. However, TUNEL analysis at E9.5 
recognized an increase in apoptosis and cellular defects of the labyrinth and giant cells of 
the placenta.Unlike what was found in teratoma epithelial tissue, γ-H2AX at E6.5 
indicated that DNA damage was not present at elevated levels in early embryos. This 
suggests that the E2F activators are dispensable in early embryogenesis up to E9.5, and 
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that they are unlikely to significantly regulate cell death, proliferation, or DNA damage 
between E3.5-E6.5 of development (Figure R & S). Notably, giant cells of the placenta 
were found to be dramatically reduced in size but did express giant cell-specific markers, 
as measured by in situ hybridization with proliferin, placental lactogen I, and placental 
lactogen II (Figure T and unpublished observation). Here, we show that E2F1-3 are 
required for development of specific lineages of the mid-gestation embryo and pinpoint 
the time during development that E2F1-3 are important for proliferation.  
Lens Cry-Cre  
  In order to more carefully evaluate cell cycle regulation we bred transgenic Cre-
expressing mice into a Cry-Cre; E2f1-/-; E2f2-/-; E2f3LoxP/LoxP genetic background. The 
Cry-Cre mice were designed to specifically express Cre in the lens epithelium and fiber 
compartment, allowing us to delete E2f3 only in the lens of the eye (Zhao 2004). This 
conditional-deletion approach was employed because the embryonic lethality that results 
from concurrent deletion of E2F1-3 would preclude the study of the lens and other organs 
of the developing embryo. The lens is a highly organized structure and serves as an ideal 
model for the study of cell cycle regulation and progression. The most anterior surface of 
the lens contains a layer of cuboidal cells. These cells are collectively referred to as the 
epithelial region. Proliferation occurs preferentially at the axis of the epithelial region. 
Proliferating epithelial cells migrate along the periphery, moving toward the posterior 
portion of the lens known as the fiber compartment. As cells enter the interior of the lens, 
they exit the cell cycle and terminally differentiate. The cells increase in size and volume 
and amass a large amount of crystallin proteins. As they complete terminal 
differentiation, cells lose their nuclei, fuse with their neighbors, and degrade membrane 
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bound organelles (Garcia et al. 2005). In order to confirm Cre expression, the Cry-Cre 
strain was crossed to the ROSA26 reporter line and lenses were stained for beta-
galactosidase (Soriano 1999)  (Figure U). 
Histological analysis of Cry-Cre; E2f1-/-; E2f2-/-; E2f3Δ/Δ was used to examine cell 
cycle progression and differentiation. Unexpectedly, total numbers of triply-deleted 
epithelial cells were reduced to 65% that of control epithelium, and the cells appeared 
considerably larger as compared to control samples. To investigate potential 
differentiation defects, lenses were stained with antibodies against alpha-, beta, and 
gamma-crystallin proteins (Figure V). These proteins are compartment specific and 
triply-deleted samples expressed equally high levels of protein as controls. Alpha-
crystallin is found in both the epithelial and fiber compartments. Meanwhile beta- and 
gamma-crystallin proteins are particular to the fiber compartment (Garcia et al. 2005). 
This suggests that triply-deleted lenses are able to differentiate and express genes typical 
of terminally differentiated lens cells.  
Lenses were also analyzed for BrdU incorporation and phosphorylated histone H3 
(P-H3) in order to check cell cycle progression through S and M phases. BrdU 
incorporation and P-H3 in lens epithelium were similar between triply-deleted and 
control samples (Figure W). Interestingly, 1% of all triply-deleted fiber cells still 
containing nuclei also incorporated BrdU. Since fiber cells are terminally differentiated 
they do not typically incorporate BrdU, suggesting that loss of E2F1-3 may have 
prevented terminal differentiation and withdrawal of the cell cycle for these cells. 
Cell death was apparent in the epithelial compartment by TUNEL as early as 
E13.5 but is most dramatic by E16.5 (Figure X). Importantly, a concentrated region of 
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DNA double strand breakage as measured by γ-H2AX appeared at the transition zone 
where cells from the epithelial compartment migrate posteriorly into the fiber 
compartment  (Figure Y). Positive staining in the fiber compartment was most likely a 
consequence of cell fusion, loss of nuclei, and break down of membrane-bound 
organelles typical of normal fiber cell maturation. Notably, similar to TUNEL results, 
H2AX staining revealed increased staining in the transition zone. 
Global gene expression data suggested that E2F target gene expression might be 
misregulated in the triply-deleted lenses (data not shown). To assess misexpression of 
E2F targets, lens sections were stained with antibodies against PCNA and Mcm3, two 
genes known to be directly regulated by E2F. The fluorescent signals in the epithelial 
cells of the lenses appeared to be more intense, and several cells within the fiber 
compartment expressed PCNA and Mcm3. The reason for the misexpression of these 
E2F target genes is poorly understood, but could be due to an increase in transcription 
during proliferation and/or a failure to properly regulate these genes during migration and 
differentiation. Importantly, E2F target gene misexpression is likely to be a driving force 
behind, if not the primary cause of, the DNA damage and cell death found in the triply-
deficient lenses. 
Though lens structure appeared normal at birth, cell death and DNA damage 
increased just prior to birth. This led us to investigate lens structure after birth. TKO mice 
21 days old had obvious phenotypic abnormalities as compared to control siblings. 
Unlike their siblings’ spherical and transparent lenses, these lenses appeared shriveled, 
asymmetrical, and cloudy (Figure Z). This indicates that, although E2F1-3 may not be 
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required for proliferation or differentiation, they may be required for cell survival and 
control of cell cycle exit in a tissue-specific manner. 
Discussion 
 The ability of cells to proliferate is a unifying characteristic that organizes life in 
mammals and higher organisms. Proliferating cells have highly specialized mechanisms 
to maintain genomic integrity. Disruption of these mechanisms can lead to uncontrollable 
growth, which destroys life rather than advancing it. Pluripotent ES cells are known to 
develop chromosomal instability when developed in culture. It is these karyotipic defects 
that present a complication for use in regenerative medicine (Mantel et al. 2007). Events 
in ES cell growth may be similar to those in tumor development which also result in 
chromosomal instability. In fact, there is an increasing body of literature that suggests 
that malignant tumors are derived from a cancer stem cell. This demonstrates that not 
only the development but maintenance of such tumors is carried out by cancer stem cells 
(Tan et al. 2006). It is the ability of these cells to self-renew and give rise to differentiated 
cells that makes them interesting to a cancer study. The presence of non-differentiated 
cells without tissue-specific markers has made it increasingly difficult to identify cancer 
stem cells, but it is in itself evidence for their existence (Zucchi et al. 2007). These 
pluripotent populations, however, are responsible for much of early embryogenesis in 
mammals. Since they are directly implicated in cancer, it is surprising that little is known 
about how these cells regulate the cell cycle. 
Cancer therapies may be advanced by the knowledge of how ES cells grow and 
proliferate. Understanding of the cell cycle in ES cells may provide fundamental 
information for preparing therapies that effectively treat malignancies. The cell cycle of 
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ES cells is characterized by an increased S phase duration and shortened gap phases, 
which likely contribute to their increased rate of proliferation. Unlike somatic cells, they 
seem to have high cyclin-dependent kinase (cdk) activity throughout the cell cycle, while 
also constitutively expressing genes that are normally cell cycle regulated (Fujii-
Yamamaoto et al. 2004). Because the E2F family, in association with pocket proteins, is 
known to regulate the cell cycle, knowledge of their role in ES cells could help us 
understand how they contribute to the processes of proliferation and differentiation. It is 
clear that ES cells act uniquely in regulating the cell cycle. The p53 tumor suppressor 
protein, which has been shown to induce apoptosis in many types of differentiated cells, 
is abundantly present in ES cells. These ES cells are able to proliferate by activating cell-
cycle checkpoints and DNA repair mechanisms unlike other cells (Prost et al. 1998). It 
has been suggested that ES cells minimally regulate cell cycle checkpoints and thereby 
allow for proliferation in these circumstances (Burdon 2001). Together, these studies 
support the notion that increasingly strict control mechanisms are utilized as an organism 
develops. 
The current study shows that the E2F activators are not essential for proliferation 
in ES cells. In vitro analysis shows that E2f1-/-;E2f2-/-;E2F3-/-  ES cells are as capable of 
proliferating as control samples. The E2F activator subclass is also not required for 
differentiation in most tissues. Teratoma analysis suggests that the activators do, 
however, play a role in maintenance of some tissues already committed to a particular 
lineage. Further, the genomic integrity of some tissues could be regulated by E2F1-3. 
Whether directly or indirectly, loss of E2F induced DNA damage and proliferation 
defects in particular tissue types. In vivo survival of triply-deficient embryos after E9.5 
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indicates that the E2F activators are dispensable in early embryogenesis. Analyses of  the 
embryonic lens and tissue from teratomas demonstrate that E2F1-3 are required in a 
tissue-specific manner. They may also be required for maintenance of genomic stability 
and activation of cell cycle checkpoints in terminally differentiated cells.  ES cells and 
precursor cells might not maintain a tightly regulated cell cycle that allows for 
proliferation and differentiation without the E2F activators. The classical view of how the 
E2F activators regulate cell cycle progression needs to be redefined as tissue specific 
requirements for the E2Fs may change their role in particular differentiation states.   
Further analysis of precursor cells in vivo may provide valuable information about how 
the cell cycle is regulated. 
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